Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2020 05:30 ET | Source: 7 Hills Pharma

7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines

HOUSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
September 16, 2020 05:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Receives $2M SBIR Grant from NCI to Launch Phase 1 Trials of Lead Immunostimulant to Augment Immuno-Oncology Drugs, COVID-19 and Flu Vaccines

HOUSTON, Sept. 16, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
August 04, 2020 05:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies

HOUSTON, Aug. 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
July 07, 2020 05:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Announces Positive Data With Oral Immunostimulant to Improve Effectiveness of COVID-19 Vaccines

Studies show the small molecule adjuvant significantly increases IgG binding antibody responses Company establishes scalable manufacturing supply chain to meet pandemic demands HOUSTON, July 07,...
June 15, 2020 10:39 ET | Source: 7 Hills Pharma

7 Hills Pharma Highlights Cell Adhesion as Key to Improving Effectiveness of Covid-19 Vaccines and Immuno-Oncology Drugs At BIO Digital 2020 Online Conference

HOUSTON, June 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
June 04, 2020 12:58 ET | Source: 7 Hills Pharma

7 Hills Pharma to Deliver Video Presentation At BIO Digital 2020 June 8 – 12

Company is leveraging its integrin platform technology to improve effectiveness of immunotherapies, including Covid-19 vaccines HOUSTON, June 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a...
April 15, 2020 08:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Announces Coronavirus Vaccine Program Targeting At-Risk Elderly

HOUSTON, April 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer and infectious diseases,...
April 14, 2020 08:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Announces FDA Clearance of Investigational New Drug Application for 7HP349, a First-in-Class Immune Stimulant

HOUSTON, April 14, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
July 24, 2018 08:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Appoints Lionel D. Lewis as Chief Medical Officer

HOUSTON, July 24, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, today announced the...
June 26, 2018 08:00 ET | Source: 7 Hills Pharma

7 Hills Pharma Announces Scientific Advisory Board Formed With Prominent Immuno-Oncology Experts to Help Advance Novel Integrin Activator Program

HOUSTON, June 26, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, announced today the formation...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right